- Molecular viologic analysis of human leukemias
-
Park CS, Yun HJ, Chun EG, Kil JY, Jo DY, Kim S, Lee BS, Paik SG
- KMID: 1688258
- Korean J Hematol.
- 1992 Oct;27(2):273-282.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of refractory anemia who obtained hematological remission to cyclosporine therapy
-
Kil JY, Yun HJ, Chun EG, Jo DY, Kim S, Kim JW, Park JW
- KMID: 1688263
- Korean J Hematol.
- 1992 Oct;27(2):317-323.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- EAP combination chemotherapy in patients with advanced head and neck cancer
-
Yoon IK, Kil JY, Chun EG, Kim JW, Kim S, Yoo JY
- KMID: 1742141
- J Korean Cancer Assoc.
- 1991 Jun;23(2):380-386.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Augmentation of cytotoxicity of anti-cancer drugs by interferons in human gastrointestinal cancer cell lines
-
Kim SC, Kil JY, Chun EG, Yun HJ, Jo DY, Kim S, Kim YK
- KMID: 1698235
- Korean J Intern Med.
- 1992 Nov;43(5):652-667.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- 3 Cases of Primary Hepatocellular Carcinoma First Detected During Pregnancy
-
Kim SI, Han SY, Yoon HD, Chun EG, Lee TS, Lee JY, Park JS, Jeon JG, Yoon BH, Shin HC
- KMID: 2036219
- Korean J Obstet Gynecol.
- 2000 Dec;43(12):2323-2327.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Suppression of chronic myelogenous leukemia colony growth and K562 cell proliferation by interleukin-1 receptor antagonist
-
Jo DY, Choi JY, Yun HJ, Chun EG, Kl JY, Kim SY, Bae YS, Choe IS
- KMID: 1688367
- Korean J Hematol.
- 1993 Nov;28(2):279-283.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Complete Remission of Choriocarcinoma with Brain Metastases Treated with Multicycle High-dose MTX/EMA-CO, Intrathecal MTX and Whole Brain RT
-
Chun EG, Rho JW, Seo SS, Yoon HD, Kim JW, Park NH, Song YS, Kang SB, Lee HP
- KMID: 2262196
- Korean J Obstet Gynecol.
- 2001 Jan;44(1):189-193.
Patients of choriocarcinoma with brain metastases are considered to have a very poor prognosis due to chemo-refractoriness and recurrence. So, selection and individualization of patients then followed by multimodality therapy... -
- CITED
-
- Close
- SHARE
-
- Close
